Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) has issued an update.
Aurobindo Pharma has notified stock exchanges that its officials will participate in an in-person analyst and investor group plant visit to its facilities in Vizag and Kakinada on March 17, 2026, scheduled from 9:00 a.m. to 5:00 p.m. Indian Standard Time. The company emphasized that the visit’s schedule may change due to exigencies and that no unpublished price-sensitive information is intended to be shared during these interactions, underscoring its adherence to disclosure and compliance norms for capital market participants.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Limited is an India-based pharmaceutical company operating in the global generics and active pharmaceutical ingredients market. The company develops, manufactures, and markets a broad range of formulations and APIs, with a significant manufacturing footprint across locations such as Vizag and Kakinada in the state of Andhra Pradesh.
Average Trading Volume: 74,567
Technical Sentiment Signal: Strong Buy
Current Market Cap: 746.8B INR
See more insights into AUROPHARMA stock on TipRanks’ Stock Analysis page.